Search in:

Human Vaccines & Immunotherapeutics Volume 8, 2012 - Issue 9: Special Focus: Cancer Commentary Series. Guest Editors: Michael G. Hanna and Alex Kudrin

Submit an article Journal homepage

Free access

1,009

Views

CrossRef citations to date

Altmetric

Special Focus Commentary

Cancer vaccines and immunotherapeutics

Challenges for pricing, reimbursement and market access

Bengt Jönsson Stockholm School of Economics; Stockholm, SwedenCorrespondence[email protected]

Nils Wilking Karolinska Institutet; Stockholm, Sweden

Pages 1360-1363 | Received 18 Aug 2012, Accepted 21 Aug 2012, Published online: 24 Aug 2012

Cite this article
https://doi.org/10.4161/hv.21921

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions
View PDF PDF

References

Seto K, Marra F, Raymakers A, Marra CA. The cost effectiveness of human papillomavirus vaccines: a systematic review. Drugs 2012; 72:715 - 43; http://dx.doi.org/10.2165/11599470-000000000-00000; PMID: 22413761
PubMed Web of Science ®Google Scholar
Favato G, Baio G, Capone A, Marcellusi A, Costa S, Garganese G, et al. Novel Health Economic Evaluation of a Vaccination Strategy to Prevent HPV-related Diseases: The BEST Study. Med Care 2012; In press http://dx.doi.org/10.1097/MLR.0b013e318269e06d; PMID: 22922435
PubMed Web of Science ®Google Scholar
Vaccinutredningen SOU. . 2010.39 http://www.regeringen.se/sb/d/12603/a/147058
Google Scholar
Regeringens proposition 2011/12:123 Ny ordning för nationella vaccinationsprogram http://www.regeringen.se/content/1/c6/18/91/62/91087d5a.pdf
Google Scholar
Joniau S, Abrahamsson PA, Bellmunt J, Figdor C, Hamdy F, Verhagen P, et al. Current vaccination strategies for prostate cancer. Eur Urol 2012; 61:290 - 306; http://dx.doi.org/10.1016/j.eururo.2011.09.020; PMID: 22001436
PubMed Web of Science ®Google Scholar
http://www.provenge.com
Google Scholar
http://www.provengereimbursement.com
Google Scholar
Nadler E, Eckert B, Neumann PJ. Do oncologists believe new cancer drugs offer good value?. Oncologist 2006; 11:90 - 5; http://dx.doi.org/10.1634/theoncologist.11-2-90; PMID: 16476830
PubMed Web of Science ®Google Scholar
http://www.tlv.se/press/ovriga-nyheter/lakemedel-mot-metastaserande kastrationsresistent-prostatacancer-kommer-inte-att-inga-i-hogkostnadsskyddet/
Google Scholar
http://www.scottishmedicines.org.uk/files/advice/abiraterone_Zytiga_FINAL_February_2012_AB_Revised_02.03.12_for_website.pdf
Google Scholar
http://www.inpharm.com/news/172644/price-cut-sways-nice-zytiga
Google Scholar
Hodi FS, O’Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363:711 - 23; http://dx.doi.org/10.1056/NEJMoa1003466; PMID: 20525992
PubMed Web of Science ®Google Scholar
Davies A, Briggs A, Schneider J, Levy A, Ebeid O, Wagner S, et al. The Ends Justify the Mean: Outcome Measures for Estimating the Value of New Cancer Therapies. Health Outcomes Research in Medicine. 2012; 3:Issue 1 e25 - 36; http://dx.doi.org/10.1016/j.ehrm.2012.01.001
Google Scholar
http://www.tlv.se/Upload/Halsoekonomiska_bedomningar/halsoekonomiskt-kunskapsunderlag-yervoy.pdf
Google Scholar
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2011/12/news_detail_001412.jsp&mid=WC0b01ac058004d5c1
Google Scholar
http://guidance.nice.org.uk/TA/Wave27/5
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Cancer vaccines and immunotherapeutics

Challenges for pricing, reimbursement and market access

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Cancer vaccines and immunotherapeutics

Challenges for pricing, reimbursement and market access

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date